ABN AMRO Investment Solutions’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.68M Buy
9,429
+723
+8% +$306K 0.03% 309
2026
Q1
$4.12M Buy
8,706
+703
+9% +$354K 0.05% 224
2025
Q4
$3.74M Buy
8,003
+7,150
+838% +$3.32M 0.06% 231
2025
Q3
$364K Sell
853
-640
-43% -$248K 0.01% 366
2025
Q2
$572K Hold
1,493
0.01% 336
2025
Q1
$516K Sell
1,493
-208
-12% -$66.9K 0.01% 333
2024
Q4
$511K Sell
1,701
-831
-33% -$290K 0.01% 351
2024
Q3
$1.03M Buy
2,532
+95
+4% +$34.8K 0.02% 309
2024
Q2
$783K Buy
2,437
+913
+60% +$297K 0.01% 334
2024
Q1
$508K Hold
1,524
0.01% 347
2023
Q4
$413K Buy
1,524
+615
+68% +$152K 0.01% 355
2023
Q3
$224K Sell
909
-95
-9% -$26K ﹤0.01% 396
2023
Q2
$305K Hold
1,004
0.01% 373
2023
Q1
$265K Buy
+1,004
New +$255K 0.01% 383

Other funds holding HCA

ABN AMRO Investment Solutions's HCA Position: Q2 2026 in Review

ABN AMRO Investment Solutions increased its HCA Healthcare (HCA) stake by 8.3% in Q2 2026, buying an estimated $306K and bringing the position to 9,429 shares worth $3.68M. The position accounts for 0.03% of the portfolio, ranked #309.

ABN AMRO Investment Solutions first reported a position in HCA in Q1 2023 and has held it in 14 quarters since. The position peaked at $4.12M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • ABN AMRO Investment Solutions held 9,429 shares of HCA Healthcare worth $3.68M as of Q2 2026.
  • ABN AMRO Investment Solutions bought 723 HCA Healthcare shares in Q2 2026, an estimated $306K.
  • HCA Healthcare made up 0.03% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #309 holding.
  • ABN AMRO Investment Solutions first reported a position in HCA Healthcare in Q1 2023 and has held it in 14 quarters since.
  • ABN AMRO Investment Solutions's HCA Healthcare position peaked at $4.12M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.